National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

recombinant transforming growth factor-beta-2
A recombinant polypeptide chemically identical to or similar to the endogenous cytokine transforming growth factor-beta-2 (TGF-beta-2). TGF-beta-2 modulates cell growth and immune function and may promote or inhibit tumor growth, depending on the tumor cell type. TGF-beta-2 may also suppress host immune system recognition of and/or response to tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:glioblastoma-derived T-cell suppressor factor
transforming growth factor-beta 2
Abbreviation:rTGF-beta-2
Acronym:TGF-beta 2

Previous:recombinant soluble human CD4 protein, recombinant thyroid-stimulating hormone, recombinant thyrotropin alfa, recombinant tissue plasminogen activator, recombinant TNF-related apoptosis-inducing ligand
Next:recombinant tumor necrosis factor family protein, recombinant tyrosinase-related protein-2, recombinant vaccinia prostate-specific antigen vaccine, recombinant vaccinia-B7.1 vaccine, recombinant vaccinia-CEA(6D)-TRICOM vaccine